Recent advances in our understanding of angiogenesis and tumor dormancy

Chinese Journal of Clinical Oncology

Volumn 35, Issue 5, 2008, Pages 293-296

  Zhang, Yu ^a   Che, Guowei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenic phenotype; Tumor dormancy; Tumor dormancy therapy

Indexed keywords

ANGIOSTATIN; ENDOSTATIN; GREEN FLUORESCENT PROTEIN; MATRIX METALLOPROTEINASE; VANDETANIB;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL POPULATION; DORMANCY; HUMAN; PHENOTYPE; TUMOR CELL; TUMOR GROWTH;

EID: 77951655050     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Naumov GN, Akslen LA, Folkman J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch[J]. Cell Cycle, 2006, 5(16): 1779-1787 (Pubitemid 44435320)
2. Indraccolo S, Favaro E, Amadori A. Dormant tumors awaken by a short-term angiogenic burst:the spike hypothesis[J]. Cell Cycle, 2006, 5(16): 1751-1755 (Pubitemid 44435317)
3. Herbst RS, Hess KR, Tran HT, et al. Phase I study of recombinant human endostatin in patients with advanced solid tumors[J]. J Clin Oncol, 2002, 20(18):3 792-3803
4. Che G, Chen J, Liu L, et al.Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981[J]. Neoplasma, 2006, 53(6): 530-537
5. Indraccolo S, Stievano L, Minuzzo S, et al. Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment [J]. Proc Natl Acad Sci U S A, 2006, 103 (11): 4216-4221
6. Udagawa T, Fernandez A, Achilles EG, et al. Persistence of microscopic human cancers in mice:alterations in the angiogenic balance accompanies loss of tumor dormancy [J]. FASEB J, 2002, 16 (11): 1361-1370 (Pubitemid 34913308)
7. Almog N, Henke V, Flores L, et al. Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis [J]. FASEB J, 2006, 20(7): 947-949 (Pubitemid 44943913)
8. Heyn C, Ronald JA, Mackenzie LT, et al. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation[J]. Magn Reson Med, 2006, 55(1): 23-29
9. Achilles EG, Fernandez A, Allred EN, et al. Heterogeneity of angiogenic activity in a human liposarcoma:a proposed mechanism for "no take" of human tumors in mice [J]. J Natl Cancer Inst, 2001, 93(14): 1075-1081
10. Naumov GN, Bender E, Zurakowski D, et al. A model of human tumor dormancy:an angiogenic switch from the nonangiogenic phenotype[J]. J Natl Cancer Inst, 2006, 98(5): 316-325 (Pubitemid 43338211)
11. Shih T, Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies[J]. Clin Ther, 2006, 28(11):1779-1802 (Pubitemid 46038527)
12. Rollin J, Régina S, Vourćh P, et al. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer [J]. Lung Cancer,2007, 56(2): 273-280
13. Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma[J]. Cancer Lett, 2006, 242(2): 151-167 (Pubitemid 44485315)
14. Wheeler C, Stephens T, Byth K, et al. Novel approaches in oncology at AstraZeneca[J]. EJC Supplements, 2003, 1(8): 3-8